Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Enliven Therapeutics Inc., 3 years.
Enliven Therapeutics Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Enliven Therapeutics Inc. June 18, 202497.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 16, 2024 | Enliven Therapeutics Inc. | Open-market sale | −33,300 | $22.14 | $737,262 |
| May 16, 2024 | Enliven Therapeutics Inc. | Open-market sale | −1,000,000 | $22.14 | $22,140,000 |
| May 17, 2023 | Enliven Therapeutics Inc. | Option exercise | +2,125 | $4.28 | $9,095 |
| Feb 23, 2023 | Enliven Therapeutics Inc. | Grant or award | +7,611,458 | — | — |
| Feb 23, 2023 | Enliven Therapeutics Inc. | Grant or award | +288,114 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.